Dangos 1 - 3 canlyniadau o 3 ar gyfer chwilio 'M.R. Cooperberg', amser ymholiad: 0.02e Mireinio'r Canlyniadau
  1. 1
    Defining intermediate-risk prostate cancer suitable for active surveillance with PSA 10-20ng/ml: Pathological outcome analysis of a population-level dataset

    Defining intermediate-risk prostate cancer suitable for active surveillance with PSA 10-20ng/ml: Pathological outcome analysis of a population-level dataset gan P.E. Lonergan, C.W. Jeong, S.L. Washington, A. Herlemann, P.R. Carroll, M.R. Cooperberg

    Cyhoeddwyd 2020-07-01
    Cael y testun llawn
    Erthygl
  2. 2
    Risk factors which predict biopsy upgrading over time in active surveillance for prostate cancer

    Risk factors which predict biopsy upgrading over time in active surveillance for prostate cancer gan P.E. Lonergan, S.L. Washington, S. Zhao, J.E. Cowan, H.G. Nguyen, K. Shinohara, M.R. Cooperberg, P.R. Carroll

    Cyhoeddwyd 2020-07-01
    Cael y testun llawn
    Erthygl
  3. 3
    Clinical utility of 4Kscore, ExosomeDx and SelectMDx and magnetic resonance imaging for the early detection of high-grade prostate cancer

    Clinical utility of 4Kscore, ExosomeDx and SelectMDx and magnetic resonance imaging for the early detection of high-grade prostate cancer gan V. Fasulo, C.M. De la Calle, J.E. Cowan, P.E. Lonergan, M. Maggi, A.J. Gadzinsky, R.A. Yeoung, A. Saita, G. Lughezzani, R. Hurle, P. Casale, M.R. Cooperberg, K. Shinohara, P.R. Carroll, H.G. Nguyen

    Cyhoeddwyd 2020-10-01
    Cael y testun llawn
    Erthygl

Offerynnau Chwilio: